Kala Bio Inc Expected To Post A Loss Of $1.70 A Share: Earnings Preview

KALA BIO

01/08/2025 14:37

KALA BIO Inc KALA.OQ KALA.O is expected to  show no change in quarterly revenue when it reports  results on August 4 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for KALA BIO Inc is for a loss of $1.70 per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for KALA BIO Inc is $12.00, about 43.6% above its last closing price of $6.77

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-1.99
-2.03
-1.41
Beat
30.5
Dec. 31 2025
-2.28
-1.74
Beat
23.7
Sep. 30 2024
-2.25
-2.43
-1.93
Beat
20.6​
Jun. 30 2024
-4.29
-4.40
-3.16
Beat
28.3
​​Mar. 31 2024
-3.02
-2.89
-4.19
Missed
-45
Dec. 31 2023
-3.62
-3.18
Beat
12.2​
Sep. 30 2023
-2.32
-2.15
-3.41
Missed
-58.3
Jun. 30 2023
-2.82
-3.19
-4.36
Missed
-36.8

This summary was machine generated August 1 at 13:37 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)